ACS to Award Clinical Research Professorship

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 9
Volume 6
Issue 9

ATLANTA, Ga-The American Cancer Society is inviting proposals from candidates for the newly established Harry and Elsa Jiler American Cancer Society Clinical Research Professorship.

ATLANTA, Ga—The American Cancer Society is inviting proposals from candidates for the newly established Harry and Elsa Jiler American Cancer Society Clinical Research Professorship.

The grant is intended for an outstanding clinician-scientist in mid-career who has made significant contributions in cancer research and is considered an exceptional leader in his or her field. Applicants may be active in any area of clinical or epidemiological cancer research.

The grant provides up to $60,000 annually that can be apportioned to salary and/or research project support at the discretion of the awardee. It is awarded for a period of five years and may be renewed once.

Applications are furnished by the American Cancer Society after discussion with the Scientific Program Director (Ralph Vogler, MD, telephone: 404-329-7542 or e-mail: rvogler@cancer.org) or the Vice President for Extramural Grants (John Stevens, MD, telephone: 404-329-7550 or e-mail: jstevens@cancer.org). The deadline for receipt of applications is October 1, 1997.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Patients treated with nivolumab in the phase 3 CheckMate 577 trial were less likely to experience progression-related treatment discontinuation vs placebo.
2 experts in this video
2 experts in this video
Considering which non–muscle-invasive bladder cancer cases may be cured by surgery alone may help mitigate overtreatment in this patient group.
Event-free survival benefit was observed among BCG-naïve patients with carcinoma in situ undergoing treatment with sasanlimab plus BCG.
Related Content